All News

PSA screening is on the rise and varies according to age, family history, race/ethnicity, and insurance status.

Androgen deprivation therapy (ADT) prior to salvage cryoablation appears to improve post-treatment morbidity to some extent but does not affect biochemical-free survival.

Results of a retrospective study provide evidence supporting the use of ultrasound as follow-up imaging to detect relapses in patients with germ cell tumors (GCT).

Here are the take-home messages from the 2012 AUA annual meeting-cutting-edge research findings in 15 areas of clinical urology.

Patients being treated with oral anticancer drugs for metastatic renal cell carcinoma (mRCC) demonstrate almost full adherence to their medication regimen, data show.

With all of the pressure on the federal government to curtail spending, the U.S. Department of Health and Human Services (HHS) is not kidding around when it comes to investigating and prosecuting Medicare fraud and abuse.

Urology drugs and devices in the pipeline from Janssen Research and Development, LLC; Auxilium Pharmaceuticals, Inc.; Tengion Inc.; Ampio Pharmaceuticals, Inc.; Tokai Pharmaceuticals, ImaginAb, Inc.; BZL Biologics, LLC; Agensys, Inc.; and Seattle Genetics, Inc.

Repeat intradetrusor injections of onabotulinumtoxinA (Botox) are associated with sustained efficacy and no new safety signals.

PSA is performing appropriately, allowing us to diagnose prostate cancers at an earlier stage and grade and allowing treatment while cure is still possible.

People, whether they need their car fixed or treatment for a urologic condition, expect high-quality service, and they are disappointed when their expectations aren't met.

Already approved for neurogenic overactive bladder, onabotulinumtoxinA (Botox) may now be on its way to garnering an indication for idiopathic OAB.

Widespread PSA screening appears to lead to improvements in pathologic outcomes.

The American Association of Clinical Urologists (AACU) rejects the USPSTF's complete disregard of the positive effect the PSA test has had on so many men in this country.

Today’s five-to-four vote by the U.S. Supreme Court to uphold the Patient Protection and Affordable Care Act (PPACA) as constitutional will result in sweeping health care system changes for all physicians and their patients.

Medical imaging is increasing, even in health maintenance organization systems, which do not have a financial incentive to conduct them, according to a recent study.

W. Hardy Hendren III, MD, a Boston-based pediatric surgeon, has received the 2012 Jacobson Innovation Award of the American College of Surgeons for his pioneering work in developing urinary undiversion surgical techniques.

Two clinical trials testing experimental drugs aimed at restoring the immune system’s ability to spot and attack cancer have shown promising early results in patients with kidney cancer, as well as those with advanced non-small cell lung cancer and melanoma.

Three leading urology associations have announced support for the USPSTF Transparency and Accountability Act of 2012 (H.R. 5998), which calls for significant changes to the U.S. Preventive Services Task Force (USPSTF) and the process by which the group makes formal recommendations regarding preventive care services.

Janssen Research & Development, LLC recently submitted a supplemental new drug application to the FDA for abiraterone acetate (ZYTIGA) intended to extend the use of abiraterone administered with prednisone to include the treatment of patients with metastatic castration-resistant prostate cancer who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and before chemotherapy.

The investigational agent radium-223 dichloride significantly increased overall survival in patients with castration-resistant prostate cancer with bone metastases, updated results of a recent phase III trial showed.

Heddy Hubbard, PhD, MPH, RN, has been named associate executive director of science and quality at the AUA.

Johnson & Johnson said its Ethicon division has informed the FDA and other regulatory bodies worldwide that it has decided to discontinue certain Gynecare vaginal mesh implants around the world.

The Urgent PC Neuromodulation System (Uroplasty, Inc., Minneapolis) demonstrated sustained safety and efficacy over 24 months in patients with overactive bladder, the authors of a recent study reported.

The American Medical Association has called on the U.S. Preventive Services Task Force (USPSTF) to incorporate consultation from specialists when preparing guidelines.

New data have added to previous evidence that the use of pioglitazone (Actos) appears to be associated with an increased risk of incident bladder cancer among patients with type 2 diabetes, Canadian researchers recently reported.

Men undergoing robot-assisted surgery for prostate cancer should look for a physician who has performed at least 1,000 surgeries and who actively seeks to improve and enhance his surgical skills to help ensure a successful post-surgery recovery of erectile function, according to a recent study.

Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen deprivation therapy than on intermittent therapy, report SWOG researchers.

The American Society for Radiation Oncology expressed disappointment in the U.S. Preventive Services Task Force's (USPSTF) final recommendations against the use of PSA-based screening for prostate cancer and strongly cautions against a blanket no-testing policy.